长循环纳米粒

[1] Porter LJ,Moghim i SM,Illum L,et al.Thepolyoxyethylene/polyoxypropylene block co-poly-m er poloxam er-407 selectively redirects intra-venously injected m icrospheres to sinusoidal en-dothelial cells of rabbit bone m arrow. FEBS Letters . 1992

[2] Torchilin VP,Papisov NI.Hypothesis: w hy dopolyethylene glycol-coated liposom es circulate solong. JLiposom e Res . 1994

[3] Douglas SJ,Davis SS,Illum L.Nanoparticles indrug delivery. Critical Reviews in Therapeutic Drug Carrier Systems . 1987

[4] Blunk T,Hochstrasser DF,Sanchez JC,et al.Colloidalcarriers for intravenous drug targeting:plasm a protein adsorption patterns on surface-m odified latex particles evaluated by tw o-dim en-sional polyacrylam ide gel electrophoresis. Electrophoresis . 1993

[5] Gref R,Minam itake Y,Peracchia MT,et al.Biodegradable long-circulating polym eric nano-spheres. Science . 1994

[6] Litzinger DC,Buiting AM,van-Rooijen N,etal.Effect ofliposom e size on the circulation tim e andintraorgan distribution of am phipathic PEG-con-taining liposom es. Biochimica et Biophysica Acta . 1994

[7] Bazile D,Prud′hom m e-C,Bassoullet MT,et al.PEG-PLA nanoparticles avoid uptake by theMPS. JPharm Sci . 1995

[8] Allem ann E.Drug-loaded nanoparticles—prepa-ration m ethods and drug targeting issues. European Journal of Pharmaceutics and Biopharmaceutics . 1993

[9] Andrade JD,Nagaoka S,CoperS,etal.Surfacesand blood com patibility currenthypotheses. ASAIO Transactions American Society for Artificial Internal Organs . 1987

[10] PassiraniC,Barratt G,DevissaguetJP,etal.In-teractions ofnanoparticles bearing heparin or dex-tran covalently bound to PMMA w ith the com ple-m ent system. Life Sciences . 1998

[1] Porter LJ,Moghim i SM,Illum L,et al.Thepolyoxyethylene/polyoxypropylene block co-poly-m er poloxam er-407 selectively redirects intra-venously injected m icrospheres to sinusoidal en-dothelial cells of rabbit bone m arrow. FEBS Letters . 1992

[2] Torchilin VP,Papisov NI.Hypothesis: w hy dopolyethylene glycol-coated liposom es circulate solong. JLiposom e Res . 1994

[3] Douglas SJ,Davis SS,Illum L.Nanoparticles indrug delivery. Critical Reviews in Therapeutic Drug Carrier Systems . 1987

[4] Blunk T,Hochstrasser DF,Sanchez JC,et al.Colloidalcarriers for intravenous drug targeting:plasm a protein adsorption patterns on surface-m odified latex particles evaluated by tw o-dim en-sional polyacrylam ide gel electrophoresis. Electrophoresis . 1993

[5] Gref R,Minam itake Y,Peracchia MT,et al.Biodegradable long-circulating polym eric nano-spheres. Science . 1994

[6] Litzinger DC,Buiting AM,van-Rooijen N,etal.Effect ofliposom e size on the circulation tim e andintraorgan distribution of am phipathic PEG-con-taining liposom es. Biochimica et Biophysica Acta . 1994

[7] Bazile D,Prud′hom m e-C,Bassoullet MT,et al.PEG-PLA nanoparticles avoid uptake by theMPS. JPharm Sci . 1995

[8] Allem ann E.Drug-loaded nanoparticles—prepa-ration m ethods and drug targeting issues. European Journal of Pharmaceutics and Biopharmaceutics . 1993

[9] Andrade JD,Nagaoka S,CoperS,etal.Surfacesand blood com patibility currenthypotheses. ASAIO Transactions American Society for Artificial Internal Organs . 1987

[10] PassiraniC,Barratt G,DevissaguetJP,etal.In-teractions ofnanoparticles bearing heparin or dex-tran covalently bound to PMMA w ith the com ple-m ent system. Life Sciences . 1998